Apyx Medical (APYX) Retained Earnings (2010 - 2026)

Apyx Medical (APYX) has reported Retained Earnings for 17 consecutive years, with $105.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings rose 12.94% year-over-year to $105.1 million; the trailing twelve-month figure through Jun 2026 stood at $105.1 million (up 12.94% YoY), and the FY2025 full-year result was $103.6 million, up 12.53% from the prior year.
• Retained Earnings advanced to $105.1 million in Q2 2026 per APYX's latest filing, from $104.0 million in the prior quarter.
• Across five years, Retained Earnings topped out at $105.1 million in Q2 2026 and bottomed at $68.0 million in Q1 2022.
• Historically, Retained Earnings has averaged $84.9 million across 5 years, with a median of $82.8 million in 2024.
• The widest YoY moves for Retained Earnings: up 13.52% in 2024, down 7.85% in 2024.
• Over 5 years, Retained Earnings stood at $73.3 million in 2022, then advanced by 10.69% to $81.1 million in 2023, then climbed by 13.52% to $92.1 million in 2024, then gained by 12.53% to $103.6 million in 2025, then climbed by 1.42% to $105.1 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $105.1 million, $104.0 million, and $103.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.